Meningitis is a kind of infection recognized by inflammation in meninges. Meninges are three protective tissue layers such as dura mater, pia mater and arachnoid mater surrounding the neuraxis. The Neuraxis constitutes the direction where the central nervous system lie. Amongst the common causes for meningitis are viruses and bacteria and rare causes are fungi and parasites. The meningitis symptoms include, vomiting, severe headache, sensitivity towards light, fever, stiff neck, along with distinctive skin rash. Bacteria-caused meningitis is more severe compared to virus-caused. Meningitis is diagnosed through carrying out blood tests for checking the bacterial/viral presence leading to the disease. A Lumbar puncture could also be carried out where cerebrospinal fluid (CSF) from the spine base is checked for bacterial/viral presence. Bacterial meningitis could be cured with several antibiotics combination.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2418
Global Meningitis Diagnostic Testing Market: Dynamics
Development of new technologies that need less time to diagnose meningitis is a key factor expected to drive growth of the global meningitis diagnostic testing market. For instance, a firm based in Ireland— HiberGene Diagnostics, in April 2018, launched ‘HG Meningococcus test’— a combined test for pneumococcal and meningococcal meningitis which offers exact results within just 40 minutes. This latest test is expected of covering bacterial meningitis 90% cases along with helping in speeding up its treatment.
Furthermore, rising development and research ad activities for diagnosing several meningitis types is expected to bolster the global meningitis diagnostic testing market growth over the forecast period. For instance, Antrum Biotech along with University of Cape Town, in July 2018, developed a novel rapid test which is able to diagnose tuberculosis (TB) meningitis in just 2 hours. This test currently is going through validations for entering the market.
However, unavailability of new diagnostics technologies for populace of emerging economies is expected to restrain the global meningitis diagnostic testing market growth. Moreover, absence of infrastructure for diagnostic laboratory in emerging economies is amongst the key restraint in growth of the global meningitis diagnostic testing market. However, this could be improved with the help of tests that don’t need laboratory support such as rapid test for the point-of-care use.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2418
Global Meningitis Diagnostic Testing Market: Regional Analysis
Based on region, the global meningitis diagnostic testing market is segregated into North America, Europe, Latin America, Asia Pacific, Africa and Middle East.
Among regions North America is expected to gain the highest share in the global meningitis diagnostic testing market during the forecast period, due to key players early adopting the diagnostic technologies. Furthermore, major North American players are focusing on adoption of collaboration and acquisition strategies for enhancing their market position. This is expected to bolster growth of the global meningitis diagnostic testing market. For instance, Quest Diagnostics, in September 2018, acquired the Oxford Immunotec’s laboratory services business in the U.S. The acquisition is expected to proliferate Quest Diagnostics’s capabilities in diagnostics of infectious disease for accelerating the company’s growth by rising diagnostic innovation access.
Furthermore, presence of major market players in the Asia Pacific region is expected to drive the global meningitis diagnostic testing market growth in the region. For instance, Seegene Inc., in May 2017, announced its entry into a latest agreement of strategic collaboration with Thermo Fisher Scientific, based on India. This collaboration was submitted for clearance from the U.S Food and Drug Administration (FDA) for the Seegene Inc.’s diagnostic assay – AllplexTM. Thermo Fisher applied for clearance from the U.S. FDA for running Seegene’s assays over QuantStudio 5 Real-Time PCR System by Thermo Fisher.
Increasing meningitis prevalence within Africa is expected to register robust growth in the global meningitis diagnostics market within this region. For instance, as per the February 2018 report from World Health Organization (WHO), majority meningococcal disease epidemics have place in the meningitis belt in Africa (Lapeysonnie). The epidemics are of an extreme disruptive nature, needing the developments of emergency treatment center for offering adequate treatment of patients within the region.
Global Meningitis Diagnostic Testing Market: Competitive Landscape
Major players functioning in the global meningitis diagnostic testing market are, Thermo Fisher Scientific, Inc., Siemens, BioFire Diagnostics, Quest Diagnostics, Luminex Corporation, Bio-Rad Laboratories, Inc., Seegene Inc., ELITechGroup, IMMY, Abbott, Nuron Biotech, Pfizer, GSK, Sanofi, MedImmune, Merck & Co., Novartis, Baxter and Biomed Pvt. Ltd.
Global Meningitis Diagnostic Testing Market: Key Development
- Eurofins Viracor, Inc., in 2018, has introduced a test for bacterial meningitis – 16S Next Generation Sequencing (NGS) to diagnose meningitis.
- Fast Track Diagnostics, in 2018, partnered with University of Liverpool for creating a commercial blood test for enhancing the diagnosis and management meningitis within patients.
- HiberGene Diagnostics, in 2015, received the approval from CE mark for its HG Meningococcus, the rapid test to diagnose bacterial meningitis.
Global Meningitis Diagnostic Testing Market: Taxonomy
On the basis of Infection Type
On the basis of Test Type
- ELISA Tests
- Lateral Flow Assay Tests
- Latex Agglutination Tests
- PCR Assay Tests
- Culture Test
On the basis of End User
- Ambulatory Surgical Centers
- Diagnostic Laboratories
On the basis of Region
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027